A Clinical study to evaluate the effect of Shilajit Rasayana and Varuna Shigru Guggulu after Basti treatment in patients of Benign Prostatic Hyperplasia (Vatashteela)in control and sample groups

A Comparative Clinical study to evaluate the effect of Shilajit Rasayana and Varuna Shigru Guggulu after Basti in Benign Prostatic Hyperplasia (Vatashteela). - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084742

Enrollment

100

Registered

2025-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: american urology association symtom score range:1-19 (mild to Moderate), Male subjects aged 40 to 70 years, Enlargement of median and lateral lobes of prostate- USG finding, Post void retention of urine less than 100ml, normal PSA level as per age range, subjects willing to participate in the study and ready to sign informed consent form

Exclusion criteria

Exclusion criteria: Higher PSA level to respective age range, Post void retention of urine more than 100ml, on other medicines for BPH, American urology association symptom score:20 and above, patients with Hematuria, Catheterized patients, Bed ridden or non ambulatory subjects

Design outcomes

Primary

Measure	Time frame
American urology association symptom score (7 criteria)Timepoint: 0th, 5th, 30th, 54th days	—

Secondary

Measure	Time frame
WHO-QOL indexTimepoint: 0th and 54th days	—

Countries

India

Contacts

Public ContactDr Vijayendra G Bhat

Shri Dharmasthala Manjunatheshwara college of Ayurveda and Research Centre, Kuthpady

ayurvijay25@gmail.com9448139919

Outcome results